Nuria Lloberas
Overview
Explore the profile of Nuria Lloberas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lloberas N, Elens L, de Winter B
Front Pharmacol
. 2025 Feb;
15:1519295.
PMID: 39906394
No abstract available.
2.
Lloberas N, Vidal-Alabro A, Colom H
Ther Drug Monit
. 2025 Jan;
47(1):141-151.
PMID: 39774592
Different polymorphisms in genes encoding metabolizing enzymes and drug transporters have been associated with tacrolimus pharmacokinetics. In particular, studies on CYP3A4 and CYP3A5, and their combined cluster have demonstrated their...
3.
Codina S, Oliveras L, Ferreiro E, Rovira A, Coloma A, Lloberas N, et al.
Front Nephrol
. 2024 Nov;
4:1470926.
PMID: 39606581
Introduction: Cardiac surgery-associated acute kidney injury (CSA-AKI) is a well-known complication that increases morbidity and mortality rates. The objective of this study was to reduce CSA-AKI through nephrologist intervention in...
4.
Fernandez-Alarcon B, Nolberger O, Vidal-Alabro A, Rigo-Bonnin R, Grinyo J, Melilli E, et al.
Front Pharmacol
. 2024 Oct;
15:1456565.
PMID: 39364055
Aims: The once-daily extended-release tacrolimus formulation (ER-Tac) has demonstrated similar efficacy and safety to the twice-daily immediate-release formulation (IR-Tac), but few population-based pharmacokinetic models have been developed in kidney transplant...
5.
Masuda S, Lemaitre F, Barten M, Bergan S, Shipkova M, van Gelder T, et al.
Ther Drug Monit
. 2024 Sep;
47(1):4-31.
PMID: 39331837
The Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology established the second consensus report to guide therapeutic drug monitoring (TDM) of everolimus (EVR)...
6.
Otero A, Rossello-Palmer E, Codina S, Lloberas N, Martinez Y, Santos N, et al.
Kidney Int Rep
. 2024 Sep;
9(9):2798-2802.
PMID: 39291199
No abstract available.
7.
Fava A, Couceiro C, Calatayud L, Hernandez-Hermida Y, Melilli E, Montero N, et al.
Am J Transplant
. 2024 Aug;
24(12):2282-2291.
PMID: 39097095
Hybrid immunity, resulting from a combination of SARS-CoV-2 infection and vaccination, offers robust protection against COVID-19 in the general population. However, its impact on immunocompromised patients remains unexplored. We investigated...
8.
Martinez Valenzuela L, Vidal-Alabro A, Rubio B, Anton-Pampols P, Gomez-Preciado F, Fulladosa X, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928186
The inflammasome regulates the innate inflammatory response and is involved in autoimmune diseases. In this study, we explored the levels of IL-18 and IL-1β in serum and urine and the...
9.
Oliveras L, Coloma A, Lloberas N, Lino L, Fava A, Manonelles A, et al.
Transplant Rev (Orlando)
. 2024 May;
38(3):100856.
PMID: 38723582
Post-transplant diabetes mellitus (PTDM) is a frequent complication after kidney transplantation (KT). This systematic review investigated the effect of different immunosuppressive regimens on the risk of PTDM. We performed a...
10.
Vidal-Alabro A, Colom H, Fontova P, Cerezo G, Melilli E, Montero N, et al.
Nefrologia (Engl Ed)
. 2024 Apr;
44(2):204-216.
PMID: 38614890
Background And Justification: The strategy of the concentration-dose (C/D) approach and the different profiles of tacrolimus (Tac) according to the cytochrome P450 polymorphisms (CYPs) focus on the metabolism of Tac...